CAS: 1702259-66-2
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
H3B-6527 REF: AN-AG00ABSCCAS: 1702259-66-2 | 97% | 179,00 €~1.016,00 € | Jue 09 May 24 | |
H3B-6527 REF: TM-T7738CAS: 1702259-66-2 | 99.85% | 87,00 €~1.040,00 € | Jue 16 May 24 | |
H3B-6527 REF: 3D-CTC25966CAS: 1702259-66-2 | Min. 95% | A consultar | Jue 20 Jun 24 |
Ref: AN-AG00ABSC
1mg | 179,00 € | |
5mg | 318,00 € | |
10mg | 481,00 € | |
50mg | 535,00 € | |
100mg | 831,00 € | |
250mg | 1.016,00 € |
Entrega estimada en Estados Unidos, el Jueves 9 de Mayo de 2024
H3B-6527
CAS:1702259-66-2
H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma, with antineoplastic …
Fórmula:
C29H34Cl2N8O4
Pureza:
99.85%
Forma y color:
Solid
Peso molecular:
629.54
Ref: TM-T7738
1mg | 87,00 € | |
2mg | 133,00 € | |
5mg | 178,00 € | |
10mg | 311,00 € | |
25mg | 518,00 € | |
50mg | 732,00 € | |
100mg | 1.040,00 € | |
1ml*10 (DMSO) | 276,00 € |
Entrega estimada en Estados Unidos, el Jueves 16 de Mayo de 2024
H3B-6527
CAS:1702259-66-2
H3B-6527 is a novel, potent and reversible CDK4/6 inhibitor that has been shown to inhibit …
Fórmula:
C29H34Cl2N8O4
Pureza:
Min. 95%
Peso molecular:
629.54 g/mol
Ref: 3D-CTC25966
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 20 de Junio de 2024